STERIS Corp  

(Public, NYSE:STE)   Watch this stock  
Find more results for Lynn Roth´┐Ż
66.83
May 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 49.78 - 71.39
Open     -
Vol / Avg. 0.00/698,798.00
Mkt cap 3.99B
P/E 29.72
Div/yield 0.23/1.38
EPS 2.25
Shares 59.72M
Beta 0.98
Inst. own 119%
Aug 3, 2015
Q1 2016 STERIS Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 11, 2015
STERIS Corp Extraordinary Shareholders Meeting Add to calendar
May 7, 2015
Q4 2015 STERIS Corp Earnings Call - Webcast
May 7, 2015
Q4 2015 STERIS Corp Earnings Release
Mar 2, 2015
STERIS Corp at Raymond James Institutional Investors Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2015
Net profit margin 8.25% 7.30%
Operating margin 13.61% 12.28%
EBITD margin - 17.13%
Return on average assets 8.05% 6.78%
Return on average equity 15.48% 12.80%
Employees 7,600 -
CDP Score - -

Address

5960 HEISLEY RD
MENTOR, OH 44060-1834
United States - Map
+1-440-3542600 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions. It offers support to the operating room, as well as to the sterile processing functions where instruments are reprocessed between surgeries and gastrointestinal procedures. The Life Sciences segment serves the pharmaceutical manufacturers and research organizations by providing decontamination and sterilization technologies, products and services. The Isomedix segment provides ethylene oxide and gamma irradiation services on a contract basis through a network of facilities in North America, where STERIS processes medical devices and other products.

Officers and directors

Jack P. Wareham Independent Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Walter M. Rosebrough Jr. President, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Michael J. Tokich Chief Financial Officer, Senior Vice President, Treasurer
Age: 45
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kathleen Lynn Bardwell Senior Vice President, Chief Compliance Officer
Age: 58
Bio & Compensation  - Reuters
David Allen Johnson Senior Vice President - Global Surgical Solutions
Age: 52
Bio & Compensation  - Reuters
Robert E. Moss Senior Vice President, Group President - STERIS Isomedix Services and Life Sciences
Age: 69
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Sudhir K. Pahwa Senior Vice President - Infection Prevention Technologies
Age: 61
Bio & Compensation  - Reuters
J. Adam Zangerle Vice President, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
Suzanne V. Forsythe Vice President - Human Resources
Age: 60
Bio & Compensation  - Reuters
Richard C. Breeden Independent Director
Age: 66
Bio & Compensation  - Reuters